Incidence and Determinants of Bacterial Infections in HIV‐Positive Patients Receiving Anti‐Pneumocystis carinii/Toxoplasma gondii Primary Prophylaxis Within a Randomized Clinical Trial

@article{Murri2001IncidenceAD,
  title={Incidence and Determinants of Bacterial Infections in HIV‐Positive Patients Receiving Anti‐Pneumocystis carinii/Toxoplasma gondii Primary Prophylaxis Within a Randomized Clinical Trial},
  author={Rita Murri and A Ammassari and Patrizio Pezzotti and Antonella Cingolani and Andrea De Luca and Federico Pallavicini and Rita Luciana Grillo and Armando Antinori},
  journal={JAIDS Journal of Acquired Immune Deficiency Syndromes},
  year={2001},
  volume={27},
  pages={49–55}
}
Summary: We assessed the incidence and determinants of bacteremia, pneumonia, and sinusitis/otitis in HIV‐positive people receiving cotrimoxazole (CTX) or dapsonepyrimethamine (DP) for primary prophylaxis of Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis (TE) within a randomized clinical trial. In total, 244 patients were randomized: 122 were assigned to CTX and 122 to DP. In the cohort, 22 bacteremia, 63 pneumonia, and 39 sinusitis/otitis cases were observed. Incidence rates… 
Bacterial Infections in Adult HIV-Infected Patients
TLDR
It is suggested that bacterial infections may have declined in the HAART era, as multicenter cohort studies have shown to be the case with AIDS-associated OIs, and preventive measures such as pneumococcal vaccination and smoking cessation remain effective strategies.
First Case of Toxoplasmosis Following Small Bowel Transplantation and Systematic Review of Tissue-Invasive Toxoplasmosis Following Noncardiac Solid Organ Transplantation
TLDR
The findings support a reconsideration of pretransplantation evaluation and prophylaxis strategies in SOT recipients and Toxoplasmosis is recognized following noncardiac SOT.
Parasitic infections in solid-organ transplant recipients
TLDR
An increase of donors emigrated from tropical areas and more posttransplant patients traveling to endemic areas have led to a rise in parasitic infections reported among SOT recipients.
Parasitic infections in solid organ transplant recipients.

References

SHOWING 1-10 OF 42 REFERENCES
Community‐acquired bacteremia in HIV‐positive patients: protective benefit of co‐trimoxazole
TLDR
PCP prophylaxis with TMP‐SMX apparently protects against communityacquired bacteremia in HIV‐infected persons.
Impact of bacterial pneumonia and Pneumocystis carinii pneumonia on human immunodeficiency virus disease progression. Pulmonary Complications of HIV Study Group.
  • D. Osmond, D. Chin, P. Hopewell
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 1999
TLDR
Results suggest that both P. carinii pneumonia and bacterial pneumonia are associated with a significantly worse subsequent HIV disease course and the proportion of cases occurring in association with a CD4 lymphocyte count of >200 suggest that measures to prevent bacterial pneumonia should be emphasized.
Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users.
TLDR
Smoking illicit drugs had the strongest effect on risk of bacterial pneumonia among HIV-seropositive IDUs with a previous history of PCP, and age between 30 and 40 yr and smoking illicit drugs (marijuana, cocaine, or crack) were associated with bacterial pneumonia.
Effect of trimethoprim-sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis on bacterial illness, Pneumocystis carinii pneumonia, and death in persons with AIDS.
TLDR
Use of TMP-SMX PCP prophylaxis significantly reduced the risks of death and of PCP and was associated with a trend toward reduced risk of major bacterial infections.
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
TLDR
In patients with advanced HIV infection, strategies that start with trimethoprim-sulfamethoxazole or with high-dose dapsone, rather than aerosolized pentamidine, are superior in patients with fewer than 100 CD4+ lymphocytes per cubic millimeter.
Frequency and risk factors of infectious complications in neutropenic patients infected with HIV
TLDR
Overall, infectious episodes in neutropenic HIV‐infected patients appear lower than in patients with haemobiologic malignancies, and neutropenia induced by zidovudine, gangiclovir or TMP‐SMX is less complicated by infectious episodes than neutropeni induced by antineoplastic chemotherapy.
Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus.
TLDR
Findings reconfirm the efficacy of TMP-SMZ in preventing community-acquired pneumonia and suggest hospitalization for pneumonia might represent a missed opportunity to encourage HIV-infected patients to enter into regular medical care and to adhere to prescribed antiretroviral and prophylaxis medications.
Intermittent Trimethoprim-Sulfamethoxazole Compared with Dapsone-Pyrimethamine for the Simultaneous Primary Prophylaxis of Pneumocystis Pneumonia and Toxoplasmosis in Patients Infected with HIV
TLDR
The prolonged half-life of dapsone and the results of in vitro and in vivo studies suggest a potential efficacy for intermittent daps one-pyrimethamine regimens in the prophylaxis of P. carinii pneumonia and toxoplasmosis in patients infected with HIV who were at risk for these other infections.
Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group.
TLDR
Bacterial pneumonia is more frequent in HIV-positive persons than in seronegative controls, and the risk is highest among those with CD4 lymphocyte counts below 200 per cubic millimeter and among injection-drug users.
...
1
2
3
4
5
...